IART in the 13F filings
Integra Lifesciences Holdings Corp · CUSIP 457985208
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 11 Feb 2026
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 2 listed it in both
- Shares listed
- 9,884,574
- combined, among listed positions
- Reported value
- $123m
- combined, at the quarter end
Among the 92 comparable managers: 13 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +696,721.
Managers listing IART in Q4 2025
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Neuberger Berman Group LLCexisting position · 2,077,180 shares now+541,996
- Citadel Advisors LLCnew position · 255,807 shares now+255,807
- Jane Street Group LLCexisting position · 200,179 shares now+180,581
- Balyasny Asset Management LLCexisting position · 136,285 shares now+111,165
- ExodusPoint Capital Management LPnew position · 101,446 shares now+101,446
Reductions
- Two Sigma Advisers LPexisting position · 194,300 shares now-176,700
- Two Sigma Investments LPexisting position · 353,264 shares now-166,102
- D. E. Shaw & Co.existing position · 469,597 shares now-155,554
- Millennium Management LLCexisting position · 148,971 shares now-75,995
- Voloridge Investment Management LLCexisting position · 433,388 shares now-60,570
New positions and exits
New (4)
Exited (2)
- Susquehanna International Group LLPwas $551k
- Schonfeld Strategic Advisors LLCwas $185k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 1 | $447k | n.a. | n.a. |
| Q3 2013 | 2 | $523k | n.a. | n.a. |
| Q4 2013 | 1 | $587k | n.a. | n.a. |
| Q1 2015 | 2 | $13m | n.a. | n.a. |
| Q2 2015 | 2 | $347m | n.a. | n.a. |
| Q3 2015 | 5 | $370m | n.a. | n.a. |
| Q4 2015 | 3 | $408m | n.a. | n.a. |
| Q1 2016 | 4 | $378m | n.a. | n.a. |
| Q2 2016 | 5 | $494m | n.a. | n.a. |
| Q3 2016 | 4 | $550m | n.a. | n.a. |
| Q4 2016 | 8 | $639m | n.a. | n.a. |
| Q1 2017 | 9 | $472m | n.a. | n.a. |
| Q2 2017 | 6 | $823m | n.a. | n.a. |
| Q3 2017 | 5 | $963m | n.a. | n.a. |
| Q4 2017 | 3 | $999m | n.a. | n.a. |
| Q1 2018 | 3 | $1.2bn | n.a. | n.a. |
| Q2 2018 | 10 | $1.7bn | n.a. | n.a. |
| Q3 2018 | 6 | $1.9bn | n.a. | n.a. |
| Q4 2018 | 7 | $1.1bn | n.a. | n.a. |
| Q1 2019 | 8 | $986m | n.a. | n.a. |
| Q2 2019 | 7 | $1.1bn | n.a. | n.a. |
| Q3 2019 | 5 | $1.1bn | n.a. | n.a. |
| Q4 2019 | 5 | $1.1bn | n.a. | n.a. |
| Q1 2020 | 7 | $855m | n.a. | n.a. |
| Q2 2020 | 5 | $892m | n.a. | n.a. |
| Q3 2020 | 6 | $992m | n.a. | n.a. |
| Q4 2020 | 6 | $1.4bn | n.a. | n.a. |
| Q1 2021 | 4 | $1.5bn | n.a. | n.a. |
| Q2 2021 | 6 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 6 | $1.7bn | n.a. | n.a. |
| Q4 2021 | 6 | $1.6bn | n.a. | n.a. |
| Q1 2022 | 8 | $1.3bn | n.a. | n.a. |
| Q2 2022 | 10 | $969m | n.a. | n.a. |
| Q3 2022 | 14 | $702m | n.a. | n.a. |
| Q4 2022 | 11 | $946m | n.a. | n.a. |
| Q1 2023 | 11 | $864m | n.a. | n.a. |
| Q2 2023 | 12 | $492m | n.a. | n.a. |
| Q3 2023 | 13 | $481m | n.a. | n.a. |
| Q4 2023 | 10 | $530m | 5 | 6 |
| Q1 2024 | 8 | $378m | 7 | 2 |
| Q2 2024 | 6 | $212m | 3 | 4 |
| Q3 2024 | 3 | $87m | 2 | 1 |
| Q4 2024 | 3 | $60m | 2 | 2 |
| Q1 2025 | 3 | $34m | 1 | 2 |
| Q2 2025 | 2 | $2.8m | 1 | 2 |
| Q3 2025 | 2 | $1.8m | 0 | 2 |
| Q4 2025 | 1 | $662k | 13 | 11 |
| Q1 2026 | 1 | $679k | 13 | 11 |
| Q2 2026 | 1 | $1.8m | 14 | 12 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IART and LLY →IART and JNJ →IART and VRTX →Choose a stock to compare with IART →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IART, latest filings →Back to the 13F Explorer →